Fda Refused To Recommend The Use Of Abiocor Total Artificial Heart

If your heart can not make you get through thisattack patients with these conditions. Abiomed Inc. is
month, if you do not have other methods oftrying to get a "humanitarian device exemption" to
treatment, if you would very much like to read thesell their products.
world slower to catch, are you willing to accept aMany experts have expressed concern that this new
fully artificial heart. U.S. Food and Drug Administrationtechnology, because some patients after the
(FDA) scientists in the 23 through the intenseoperation experienced tremendous pain. Abiomed said
discussion, very difficult to make a choice: theyit produce such a dramatic impact for reasons not
refused to recommend the use of this totally artificialyet clear, it may be because the heart of the original
heart.set of flow patterns caused by changes. They need
  By the Abiomed's AbioCor artificial heart companyfurther research to find a suitable transplant patients,
has been in the 14 patients were also tested. 2 ofalso can try with medicine.
which died in the operating table, the rest will live anAt least two families, therefore the revenue
average of 5 months or so, but about half of them inAs mentioned above survived 17 months of Tom, he
the final years of illness suffered relentless torture,was 71 years old. To live this in his 17 months, he
some of which even in loss of brain function in mostsaw his great-granddaughter's birth, and he also came
cases, spend the last years. Only one patient is lucky,home with the family members together and had a
his success to live for 17 months, and finally died duewonderful Thanksgiving.
to wear artificial heart. His family told the FDAAnother winner is the first transplant patients,
officials in the heart with their extension of time is59-year-old RobertTool. His wife Carol said: In his last
priceless.five months, left me with unforgettable memories. I
But FDA scientists to consider is: Is it worth riskingam very fortunate that he accepted the transplant.
the danger of under great pain to extend the time.Of course, longer and for their families who are not
Scientists disagree. From the University of Texas Dr.enough.
ClydeYancey not worth the risk, while those fromBut there is also a widow of the transplant is not
Columbia University, Dr. JudahWeinberger this givessatisfied, she thinks a doctor before the transplant
rise to hope, hope is priceless.and its side effects is not fully informed, so they are
FDA scientists usually follow the recommendation, butvery sorry took part in the experiment. She
this has yet to be conclusive. FDA's Executivetherefore is preparing to sue.
JulieSwain said: "This is really a hard choice." SheAbiomed's chief research officer (CSO) RobertKung
hopes to extend the AbioCor artificial heart in humansaid he very much hope that FDA approval of
life, not extend the time for people to die.AbioCor can be sold. So that they can be authorized
AbioCor artificial heart different from previousin 10 hospitals in the transplant surgery, so that they
products is that it is a mechanical Heart Do not needget more information to improve treatment.
a cable to charge the skin adhesive.View medical device products, go to the medical
Only those who have life-threatening, patientsdevice market ... ...
without other treatment Talent You can use thisView medical device information, information into the
new technology, in the U.S. only about 5 million heartmedical device industry ... ...